Cargando…
Intravitreal administration of bevacizumab: pros and cons
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406161/ https://www.ncbi.nlm.nih.gov/pubmed/25896903 http://dx.doi.org/10.1186/s40199-015-0110-0 |
| _version_ | 1782367733821734912 |
|---|---|
| author | Dashti-Khavidaki, Simin Abdollahi, Mohammad |
| author_facet | Dashti-Khavidaki, Simin Abdollahi, Mohammad |
| author_sort | Dashti-Khavidaki, Simin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4406161 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44061612015-04-23 Intravitreal administration of bevacizumab: pros and cons Dashti-Khavidaki, Simin Abdollahi, Mohammad Daru Editorial BioMed Central 2015-04-21 /pmc/articles/PMC4406161/ /pubmed/25896903 http://dx.doi.org/10.1186/s40199-015-0110-0 Text en © Dashti-Khavidaki and Abdollahi; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Editorial Dashti-Khavidaki, Simin Abdollahi, Mohammad Intravitreal administration of bevacizumab: pros and cons |
| title | Intravitreal administration of bevacizumab: pros and cons |
| title_full | Intravitreal administration of bevacizumab: pros and cons |
| title_fullStr | Intravitreal administration of bevacizumab: pros and cons |
| title_full_unstemmed | Intravitreal administration of bevacizumab: pros and cons |
| title_short | Intravitreal administration of bevacizumab: pros and cons |
| title_sort | intravitreal administration of bevacizumab: pros and cons |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406161/ https://www.ncbi.nlm.nih.gov/pubmed/25896903 http://dx.doi.org/10.1186/s40199-015-0110-0 |
| work_keys_str_mv | AT dashtikhavidakisimin intravitrealadministrationofbevacizumabprosandcons AT abdollahimohammad intravitrealadministrationofbevacizumabprosandcons |